Status:
UNKNOWN
The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Lead Sponsor:
Siriraj Hospital
Conditions:
Alopecia Areata
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Alopecia areata is one of the most common cause of non-scarring alopecia. The pathogenesis is still unclear, however, it is believed to be an autoimmune disease. This disease is not a life-threatening...
Detailed Description
Inclusion criteria 1. Patients must be above 18 years old 2. Newly diagnosed with multiple alopecia areata 3. Patient has lesions on the both side of the scalp. 4. Lesions's diameter varies between 2...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients must be above 18 years old
- Newly diagnosed with multiple alopecia areata
- Patient has lesions on the both side of the scalp.
- Lesions's diameter varies between 2-6 cms
- Exclusion criteria
- Having active scalp inflammation
- Allergic to botulinum toxin A or human albumin
- Receiving any medication that interfere efficacy of botulinum toxin such as macrolides antimicrobial agents or neuromuscular medications
- Diagnosed with neuromuscular diseases such as Myasthenia gravis
- Pregnant, breast feeding, plan to pregnant patients
Exclusion
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00999869
Start Date
November 1 2009
End Date
February 1 2013
Last Update
August 7 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj hospital
Bangkok, Bangkok, Thailand, 10700
2
Department of Dermatology, Faculty of medicine Siriraj Hospital, Mahidol University
Bangkok, Thailand, 10700